These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 1972206

  • 21. [Effect of nitrates, nitrate-like substances, calcium antagonists and beta-adrenergic receptor blockers on peripheral circulation].
    Busse R, Bassenge E.
    Herz; 1982 Dec; 7(6):388-405. PubMed ID: 6131027
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha 2-adrenoceptor agonists by diltiazem and verapamil.
    Cavero I, Shepperson N, Lefèvre-Borg F, Langer SZ.
    Circ Res; 1983 Feb; 52(2 Pt 2):I69-76. PubMed ID: 6131754
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J.
    J Cardiovasc Pharmacol; 1994 Feb; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [Abstract] [Full Text] [Related]

  • 27. [Calcium antagonists: sites of action, pharmacologic effect profile and clinical use. 2: Pharmacologic effects, indications and side effects of calcium antagonists].
    Bluth R, Langnickel R.
    Z Arztl Fortbild (Jena); 1986 Feb; 80(6):237-40. PubMed ID: 2424182
    [No Abstract] [Full Text] [Related]

  • 28. Nifedipine and alpha adrenoceptors in rat aorta. II. Role of extracellular calcium in enhanced alpha-2 adrenoceptor-mediated contraction in diabetes.
    Scarborough NL, Carrier GO.
    J Pharmacol Exp Ther; 1984 Dec; 231(3):603-9. PubMed ID: 6094794
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Subacute sepsis impairs vascular smooth muscle contractile machinery and alters vasoconstrictor and dilator mechanisms.
    Price SA, Spain DA, Wilson MA, Harris PD, Garrison RN.
    J Surg Res; 1999 May 01; 83(1):75-80. PubMed ID: 10210646
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Calcium antagonists and alpha 2-adrenoceptors: possible role of extracellular calcium ions in alpha 2-adrenoceptor-mediated vasoconstriction.
    van Zwieten PA, van Meel JC, Timmermans PB.
    J Cardiovasc Pharmacol; 1982 May 01; 4 Suppl 3():S273-9. PubMed ID: 6184552
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. New alpha 1-adrenergic receptor antagonists for the treatment of hypertension: role of vascular alpha receptors in the control of peripheral resistance.
    Cubeddu LX.
    Am Heart J; 1988 Jul 01; 116(1 Pt 1):133-62. PubMed ID: 2899387
    [Abstract] [Full Text] [Related]

  • 38. New developments in alpha-adrenergic receptor pharmacology: implications for the initial treatment of hypertension.
    Colucci WS.
    Am J Cardiol; 1983 Feb 24; 51(4):639-43. PubMed ID: 6131604
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.